Submission Details
| 510(k) Number | K241385 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2024 |
| Decision Date | July 13, 2024 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K241385 is an FDA 510(k) clearance for the Omnifix Syringe NRFit, a Piston Syringe With Neuraxial Connector ? Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact (Class II — Special Controls, product code QEH), submitted by B.Braun Medical, Inc. (Bethlehem, US). The FDA issued a Cleared decision on July 13, 2024, 59 days after receiving the submission on May 15, 2024. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5860.
| 510(k) Number | K241385 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2024 |
| Decision Date | July 13, 2024 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | QEH — Piston Syringe With Neuraxial Connector ? Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5860 |
| Definition | A Neuraxial Piston Syringe Is Intended To Inject Or Withdraw Fluid From The Neuraxial Space With Neuraxial Specific Connections. This Product Code May Include Epidural, Peripheral, Subarachnoid/spinal Block, Intrathecal And/or Intracerebroventricular Administration Routes. The Connector For Neuraxial Applications Is Intended To Facilitate Ansi/aami/iso 80369-6:2016 Compliant Neuraxial Specific Connections. |